
Enlivex Therapeutics Ltd. ENLV
€ 0.66
-4.12%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
Enlivex Therapeutics Ltd. Finanzkreislauf 2011-2026 | ENLV
Finanzkreislauf Jährlich Enlivex Therapeutics Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -193 | -106 | -18.4 | -368 | -1.03 K | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -18.4 | -1.03 K | -344 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
3.11 K | - | 5743.5 % | $ 69.7 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Exelixis
EXEL
|
-8.32 | $ 48.16 | 4.22 % | $ 13.1 B | ||
|
Fortress Biotech
FBIO
|
-74.9 | $ 2.39 | -0.42 % | $ 66.7 M | ||
|
Compugen Ltd.
CGEN
|
-82.7 | $ 2.9 | 1.4 % | $ 271 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
257 | $ 22.4 | -0.71 % | $ 3.71 B | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.14 | - | $ 653 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Gilead Sciences
GILD
|
115 | $ 131.33 | -2.04 % | $ 163 B | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 21.17 | 2.47 % | $ 2.69 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.1 | 0.5 % | $ 5.51 B | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 54.83 | 4.6 % | $ 4.93 B | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.57 | -2.48 % | $ 418 M |